Asymmetrically Coated Tablet for Zero-Order Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional oral extended release dosage forms often fail to maintain a consistent drug release rate, as the varying surface area exposed during dissolution leads to non-zero-order kinetics, making it difficult to achieve precise control over immediate, time-delayed, or pulsatile drug release.
Innovation Solution
Asymmetrically coated tablets with regions of different dissolution rates, ensuring a constant cross-sectional area is exposed to the dissolution medium, thereby maintaining a constant drug release rate through the use of water-soluble and water-insoluble polymers in specific configurations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If conventional tablets with varying surface area are used during dissolution, then the tablet dissolves completely, but the drug release rate varies and does not maintain zero-order kinetics
Solution Approach 1:
The patent applies asymmetry by coating only a portion of the tablet surface with dissolution-resistant material, creating an asymmetric coating pattern. This asymmetric design maintains a constant exposed cross-sectional area during dissolution, ensuring zero-order drug release kinetics while allowing complete tablet dissolution.
Solution Approach 2:
The patent implements local quality by applying different coating properties to different regions of the tablet. Specifically, certain areas are coated with dissolution-resistant material while other areas remain uncoated or have different coating characteristics, allowing precise control over the dissolution interface geometry to maintain constant surface area exposure.
2Loss of time
If uniform coating is applied to control drug release, then time-delayed release can be achieved, but the same kinetic problems reoccur when the coating dissolves and the tablet shape is exposed
Solution Approach 1:
The patent applies segmentation by dividing the coating into functionally distinct regions: a first region with rapid dissolution rate for immediate or time-delayed release, and a second region with slower dissolution rate to maintain constant cross-sectional area exposure. This segmented approach allows precise control over release timing while preventing the kinetic problems that occur with uniform coatings.
Solution Approach 2:
The patent implements preliminary action by designing the asymmetric coating structure in advance, where the geometry and dissolution rates of different coating regions are predetermined to maintain a constant exposed cross-sectional area throughout the dissolution process. This pre-planned asymmetric design prevents the need for real-time adjustments and ensures consistent zero-order release kinetics.
3Duration of action of stationary object
If the tablet geometry changes during dissolution, then complete dissolution occurs, but the varying surface area exposes different portions of the core to the dissolution medium, changing the release rate
Solution Approach 1:
The patent uses asymmetry to create a coating pattern where the exposed surface area remains constant during dissolution. By strategically placing dissolution-resistant coating material, the design ensures that as the tablet dissolves, the cross-sectional area exposed to the dissolution medium stays constant, maintaining a steady drug release rate throughout the dissolution process.
Solution Approach 2:
The patent applies dimensionality change by focusing on maintaining a constant cross-sectional area (two-dimensional parameter) rather than controlling the entire surface area. This dimensional approach allows the tablet to dissolve completely in three dimensions while maintaining a stable two-dimensional exposure interface, ensuring consistent release kinetics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for precise control over immediate and time-delayed release profiles, achieving zero-order or first-order extended release and pulsatile release kinetics, matching or improving upon commercially available pharmaceuticals like Toprol XL and Glucotrol XL.
Implementation Method 1
The coatings may include drugs in varying concentrations. Further, different regions of the coating may have different rates of dissolution.
Implementation Method 2
As the tablet is dissolved, the drug is released at a predicted rate.
Data Source
AI summary
A tablet for the controlled release of a drug. The tablet is in the form of an asymmetrically coated tablet so that immediate release or time-delayed release times can be precisely controlled and the extended release slab may provide zero-order or first-order extended release and pulsatile release depending on the excipients used in the tablet formulations. The core of the tablet is coated with an asymmetrical coating, that is, a coating with regions having different properties. The coatings may include drugs in varying concentrations. Further, different regions of the coating may have different rates of dissolution. The core of the tablet may be provided with a constant cross-sectional area along a longitudinal length of the tablet, a coating having a first region with a more rapid rate of dissolution than a second region. The dissolution of the first region exposes only the cross-sectional area to the dissolution medium. The second region of the coating prevents any other portion of the core of the tablet from being exposed to the dissolution medium. Therefore, since the cross-sectional area remains constant as it is dissolved, the rate of release of the drug from the core of the tablet remains constant. The cross-sectional area may be of any geometrical configuration so long as the area remains constant as the core dissolves.